Telehealth is the future of healthcare in america and around the world. Most people don’t want to wait hours in the hospital or even weeks for an appointment. Telehealth offers those services the same day. If we can implement those services online, a lot of problem can be avoided. As of LifeMD, it is easy to look at their financial statements and see that the company is undervalued. Revenue is almost as the same as the marketcap. The only thing keeping this stock from hitting $10 is WorkSimply and the dilution. In my opinion, dilution is not a problem because it can keep the good employees in the company. If LifeMD can grow to be a huge company in the telehealth sector, i expect the company to do a share buyback so dilution is not a problem for me. Finally, if LifeMD can achieve profit in the next quarter and they have a positive news about the sell of WorkSimply, i expect the stock to easily reach $10-12 per share.
How well do narratives help inform your perspective?
Disclaimer
The user MathieuMRoy has a position in NasdaqGM:LFMD. Simply Wall St has no position in any of the companies mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The author of this narrative is not affiliated with, nor authorised by Simply Wall St as a sub-authorised representative. This narrative is general in nature and explores scenarios and estimates created by the author. The narrative does not reflect the opinions of Simply Wall St, and the views expressed are the opinion of the author alone, acting on their own behalf. These scenarios are not indicative of the company's future performance and are exploratory in the ideas they cover. The fair value estimates are estimations only, and does not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that the author's analysis may not factor in the latest price-sensitive company announcements or qualitative material.